Covered, but the cut and the shrinking portfolio say caution. A 16.92% yield on the regular $0.17 quarterly dividend is covered by net investment income — $0.22 per share in Q2 2026 against the $0.17 dividend, about a 77% payout (81% on adjusted NII of $0.21). But the dividend was cut 41% in 2026 from $0.29, NAV per share fell to $6.58 from $6.72 in the quarter, a $523 million portfolio sale was priced at 95% of December 2025 fair value, and the board has opened a strategic review. The income covers the new rate; the double-digit yield is pay for that uncertainty, not a safe rate.
Key risk: The strategic review and the repositioning — further portfolio sales at discounts, or a review outcome that returns capital instead of reinvesting it, would shrink the income base the $0.17 dividend depends on.
Changes if: NAV stabilizes for two quarters running and NII coverage of the $0.17 rate holds, or the strategic review resolves into a clear reinvestment plan. Until then the verdict stays cautious.
- ✓Coverage check: Q2 2026 GAAP net investment income of $0.22 a share covers the $0.17 regular dividend; adjusted NII of $0.21 covers it at 81%. No supplemental is currently declared.
- !Yield check: 16.92% indicated — $0.17/qtr × 4 at the $4.02 close on Oct. 23, 2026. The yield prices in the 2026 cut and the strategic review; read it as compensation for risk, not as a safe rate.
- !NAV check: NAV per share of $6.58 at June 30, 2026, down from $6.72 at March 31, after a $523 million portfolio sale and $14.8 million of net realized losses in the quarter.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.